Du är här



GHENT, Belgium, 19 August 2015
[Euronext Brussels: ABLX; OTC: ABYLY]

will announce its half-year results for 2015 on Thursday 27 August 2015 at
7.00 am CET.

The Ablynx management team will host a conference call and webcast during
which the half-year results for 2015 will be presented, followed by a Q&A
session. This event will be held on Thursday 27 August 2015 at 4.00 pm
CET/10.00 am EST.

The conference call will be webcast live and may be accessed under theevents
sectionof the Ablynx website or by clickinghere. If you would like to
participate in the Q&A session, please dial +32 (0)2 402 30 92, confirmation
code 6867520. Shortly after the call, a replay of the webcast and copy of the
presentation will be available under theevents sectionof the Ablynx website.

About Ablynx

Ablynxis a biopharmaceutical company engaged in the development ofNanobodies®,
proprietary therapeutic proteins based on single-domain antibody fragments,
which combine the advantages of conventional antibody drugs with some of the
features of small-molecule drugs. Ablynx is dedicated to creating new
medicines which will make a real difference to society. Today, the Company
has more than30 proprietary and partnered programmesin development in various
therapeutic areas including inflammation, haematology, immuno-oncology,
oncology and respiratory disease. The Company has collaborations with
multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim,
Eddingpharm, Genzyme, Merck&Co., Merck Serono, Novartis and Taisho
Pharmaceutical. The Company is headquartered in Ghent, Belgium. More
information can be found onwww.ablynx.com.

For more information, please contact


Dr Edwin Moses
t: +32 (0)9 262 00 07
m: +32 (0)473 39 50 68
e: edwin.moses@ablynx.com

Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e: marieke.vermeersch@ablynx.com

Follow us on Twitter @AblynxABLX

Ablynx media relations
Instinctif Partners:

Sue Charles, Daniel Gooch
London office
t: +44 (0)20 7866 7905
e: ablynx@instinctif.com

Jim Rusagara
Brussels office
t: +32 (0)2 626 9500
e: ablynx@instinctif.com

pdf format of the press release


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ablynx via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.